Home
Institutions
Filings
Issuers
About
All
Index / Passive
Hedge Fund
VC / PE / Holdco
Long-Term Concentrated
Concentrated Active
Quant / Systematic
Diversified Active
NLS PHARMACEUTICS LTD
CUSIP: H57830137
Class: COM NEW
UBS Group AG's Holding History (CIK: 0001610520)
Note: Option positions (PUT/CALL) are excluded.
Q3 2025
Shares
38
Value ($000)
$0
Avg Close
—
Range
—
Q2 2025
Shares
14,982
Value ($000)
$43
Avg Close
—
Range
—
Q1 2025
Shares
25,737
Value ($000)
$40
Avg Close
—
Range
—
Q4 2024
Shares
8,292
Value ($000)
$17
Avg Close
—
Range
—
Q3 2024
Shares
4,719
Value ($000)
$24
Avg Close
—
Range
—
Period
Shares
Value ($000)
Average Close
Price Range
Q3 2025
38
$0
—
—
Q2 2025
14,982
$43
—
—
Q1 2025
25,737
$40
—
—
Q4 2024
8,292
$17
—
—
Q3 2024
4,719
$24
—
—